The PGY2 Medication-Use Safety and Policy Residency is a structured 12-month PGY2 residency program that provides advanced training in medication safety, medication-use policy, regulatory and accreditation standards, and quality improvement. Residents completing the program will be well prepared to assume roles including: those with responsibility for developing and implementing system changes that improve the safety within the medication-use system; managing medication-use guidelines and policies; and overseeing regulatory and accreditation compliance.
The resident will work closely with members of Medication Safety, Quality, and Regulatory team to investigate medication errors and near misses, develop and implement system changes to ensure safe and efficient use of medications, assess compliance with regulatory standards, and evaluate medication-use policies and guidelines to ensure alignment with evidence-based best practice recommendations. The resident will learn about the operations of a cancer center through required learning experiences, participation in formal education programs, administrative projects, and staffing in the ambulatory infusion pharmacy.
For more information, please visit our website for a detailed description of residency activities, contact information, and important deadlines.
Applicants must expect to complete an ASHP accredited PGY-1 pharmacy residency and be licensed in the state of Massachusetts by summer of 2019. Application requirements: Complete PhORCAS application by Friday, January 5, 2024.
PPS interviews will be conducted on Sunday, December 4th through Wednesday December 7th. For consideration for an interview, please send a message through the PPS messenger. Priority will be given to candidates who submit interview requests by Monday, November 27th.
Since its founding in 1947, Dana-Farber Cancer Institute in Boston, Massachusetts has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.
The mission of the Dana-Farber Cancer Institute Pharmacy Department is to provide expert pharmaceutical care to our patients as an integral member of the health care team. The Pharmacy Department also provides clinical and technical training to pharmacy students and pharmacy residents.